This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Presenter: Jason, Roberts, Brisbane, Australia
Authors: Jason Roberts
Transplant patients, like trauma, burns and critically ill patients, can develop dramatically altered pharmacokinetics (antibacterial concentrations) leading to altered pharmacodynamics (antibacterial effects, e.g. bacterial killing). Part of these altered effects may be sub-optimal rates of bacterial eradication which can predispose to the development of sub-populations of resistant pathogens leading to greater patient morbidity and potentially mortality. Minimising the emergence of antibiotic resistance may be achieved through optimized antibacterial therapy. In this presentation, the issues surrounding the emergence of resistance associated with sub-optimal dosing will be discussed as well as some key points related to optimizing dosing of specific antibiotic agents.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada